@article{957cbb7c0b274f368fbddc6c87e39393,
title = "Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department - A scientific statement from the American heart association council on clinical cardiology",
abstract = "In the United States each year, >5.3 million patients present to emergency departments with chest discomfort and related symptoms. Ultimately, >1.4 million individuals are hospitalized for unstable angina and non-ST-segment elevation myocardial infarction. For emergency physicians and cardiologists alike, these patients represent an enormous challenge to accurately diagnose and appropriately treat. This update of the 2002 American College of Cardiology/ American Heart Association Guidelines for the Management of Patients with Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction (UA/NSTEMI) provides an evidence-based approach to the diagnosis and treatment of these patients in the emergency department, in-hospital, and after hospital discharge. Despite publication of the guidelines several years ago, many patients with UA/NSTEMI still do not receive guidelines-indicated therapy.",
keywords = "AHA Scientific Statements, Acute coronary syndrome, Emergency management, Non-ST-myocardial infarction, Unstable angina",
author = "Gibler, {W. Brian} and Cannon, {Christopher P.} and Blomkalns, {Andra L.} and Char, {Douglas M.} and Drew, {Barbara J.} and Hollander, {Judd E.} and Jaffe, {Allan S.} and Jesse, {Robert L.} and Newby, {L. Kristin} and Ohman, {E. Magnus} and Peterson, {Eric D.} and Pollack, {Charles V.}",
note = "Funding Information: Authors' Disclosures Writing Group Member Employment Research Grant and Other Research Support Speakers Bureau/Honoraria Stock Ownership Consultant/Advisory Board Other W. Brian Gibler University of Cincinnati College of Medicine Millennium, Schering-Plough, iSTAT, Abbott, Biosite None None Aventis/Sanofi, Inovise Medical, Ischemia Technologies, Scios, ArgiNOx Pharmaceuticals None Christopher P. Cannon Brigham & Women's Hospital Bristol-Myers Squibb, Merck, Aventis/Sanofi, AstraZeneca AstraZeneca, Bristol-Myers Squibb, Guilford Pharmaceuticals, Merck, Millennium, Pfizer, Aventis/Sanofi, Schering-Plough, BESTmed, i3 Magnifi, New England Continuing Medical Education None AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Guilford Pharmaceuticals, Merck, Merck/Schering-Plough Partnership, Pfizer, Aventis/Sanofi, Schering-Plough, Vertex Pharmaceuticals None Andra L. Blomkalns University of Cincinnati Dept of Emergency Medicine Millennium, Schering-Plough, iSTAT, Abbott, Biosite None None Aventis/Sanofi, Inovise Medical, Ischemia Technologies, Scios, AgriNOx Pharmaceuticals None Douglas M. Char Washington University School of Medicine Inovise Medical Aventis/Sanofi, Scios None Scios None Barbara J. Drew University of California-San Francisco National Heart, Lung, and Blood Institute, Medtronic Physio-Control, Inovise Medical Philips Medical, General Electric Medical None None None Judd E. Hollander University of Pennsylvania None Aventis, Sebos None Sebos None Allan S. Jaffe Mayo Clinic Roche, Dade-Behring, Beckman-Coulter None None None None Robert L. Jesse Department of Veterans Affairs None Abbott Laboratories None Biosite, Ischemia Technologies, Crusade/DCR1 None L. Kristin Newby Duke University Medical Center Roche Diagnostics, Millennium, Novartis, Schering-Plough, Bristol-Meyers Squibb/Sanofi None None None None E. Magnus Ohman University of North Carolina None None Medtronic, Inovise Medical, Response Biomedical None None Eric D. Peterson Duke University Medical Center, Duke Clinical Research Institute Millennium, Schering-Plough, Bristol-Myers Squibb, Society of Thoracic Surgeons None None None None Charles V. Pollack University of Pennsylvania Aventis Aventis, Millennium, Schering-Plough, BMS, Sanofi, Genentech None None None This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. ",
year = "2005",
month = may,
day = "24",
doi = "10.1161/01.CIR.0000165556.44271.BE",
language = "English (US)",
volume = "111",
pages = "2699--2710",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "20",
}